Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

2.1K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.1K
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

2.8K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.8K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

12.7K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
12.7K
Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Stimulants01:29

Stimulants

1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Notes from the Field: Tobacco Product Use Among Adults - United States, 2017-2023.

MMWR. Morbidity and mortality weekly report·2025
Same author

Notes from the Field: Inspection of 59 "Vape Shops" - United States, October-November, 2016.

MMWR. Morbidity and mortality weekly report·2018
Same author

Tobacco Product Use Among Adults - United States, 2015.

MMWR. Morbidity and mortality weekly report·2017
Same author

Tobacco Use Among Middle and High School Students--United States, 2011-2015.

MMWR. Morbidity and mortality weekly report·2016
Same author

Frequency of Tobacco Use Among Middle and High School Students--United States, 2014.

MMWR. Morbidity and mortality weekly report·2015
Same author

Electronic cigarettes: analysis of FDA adverse experience reports in non-users.

Tobacco control·2015

Related Experiment Video

Updated: May 1, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

10.8K

Introduction to tobacco control supplement.

Ii-Lun Chen1, Corinne G Husten

  • 1Center for Tobacco Products, Food and Drug Administration, , Rockville, Maryland, USA.

Tobacco Control
|April 16, 2014
PubMed
Summary

Electronic cigarettes (e-cigarettes) require more research to understand their risks and benefits. The FDA is reviewing current knowledge to inform future regulation of these nicotine products.

Keywords:
Electronic nicotine delivery devicesHarm ReductionNon-cigarette tobacco products

More Related Videos

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.4K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K

Related Experiment Videos

Last Updated: May 1, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

10.8K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.4K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K

Area of Science:

  • Public Health
  • Tobacco Control
  • Regulatory Science

Background:

  • Electronic cigarettes (e-cigarettes) have rapidly gained market and media attention.
  • Limited data exists on the global impact, risks, and benefits of e-cigarettes, hindering regulatory action.
  • The U.S. Food and Drug Administration (FDA) currently does not regulate e-cigarettes marketed as tobacco products.

Discussion:

  • FDA Center for Tobacco Products scientists are reviewing existing literature to identify knowledge gaps concerning e-cigarettes.
  • Key research areas include product design, e-liquid and aerosol chemistry, toxicology, human factors, abuse liability, clinical pharmacology, health effects, pediatric issues, and environmental concerns.
  • A coordinated regulatory approach is necessary given the continuum of nicotine-containing products.

Key Insights:

  • Significant knowledge gaps exist regarding the health effects and toxicology of e-cigarettes.
  • Understanding human factors and abuse liability is crucial for effective regulation.
  • Paediatric and environmental impacts require further investigation.

Outlook:

  • Further research is essential to inform comprehensive regulatory strategies for e-cigarettes.
  • The FDA aims to develop a science-based approach to regulating the evolving e-cigarette market.
  • Addressing identified research gaps will support evidence-based public health policies.